{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"what-are-peptides-nsaids","title":"What Are Peptides for NSAIDs","body":"## What's breaking down\nNSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may damage the gut lining, liver, and other tissues. Repair pathways slow while new damage accumulates. The net result is ongoing structural stress even as symptoms feel quieter.\n\n## Why NSAIDs matters for you\n1. **Drug:** NSAIDs\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\n3. **Therefore for you:** NSAIDs primarily suppress a signal rather than reduce mechanical load or support metabolism. This trade-off can ease short-term discomfort but may delay tissue remodeling and repair cascades that rely on those same inflammatory pathways.\n\n## How these fit together\nPeptides studied alongside NSAIDs target different layers of the same problem. One layer is the inflammation NSAID use creates or fails to resolve. Another is the direct tissue injury NSAIDs can cause. A third is the slowed repair that follows signal suppression. When combined in research models, the peptide actions address cytoprotection and healing steps that the drug alone does not restore.\n\n## What the evidence actually shows\nHuman data on peptides specifically paired with NSAIDs remains absent in published trials. Preclinical (animal) studies form the main body of work. One rat study found BPC-157 reduced diclofenac-induced gastric, intestinal, liver, and brain lesions when given alongside or after the NSAID (source s1). Another rat model showed BPC-157 counteracted NSAID effects on lower esophageal and pyloric sphincter pressure and reduced associated injuries (source s2). A 2020 review summarized BPC-157's potential to stabilize intestinal permeability after NSAID exposure (source s3). These are all rodent or in-vitro findings; no equivalent controlled human trials exist for NSAID co-administration.\n\n## What scientists say\nResearchers note BPC-157's consistent cytoprotective effects in NSAID toxicity models across multiple organs in rats. They describe it as a possible adjunct for NSAID gastroenteropathy, an area with unmet needs (source s3, source s4). Human safety data for this use is described as unavailable. No large-scale clinical trials confirm translation from animal results.\n\n## What people say on Reddit\nUsers on peptide forums report taking BPC-157 while using NSAIDs and suggest spacing doses by two hours. Anecdotal accounts describe reduced gut discomfort or faster recovery from injuries while on anti-inflammatories. These remain individual experiences without controlled verification.\n\n## What people say on X\nPosts mention BPC-157 and TB-500 in contexts of injury recovery that sometimes involve prior NSAID use. Comments highlight perceived benefits for tendons or joints alongside warnings about limited human evidence and regulatory status. No consistent pattern of NSAID-specific stacking appears in recent threads.\n\n## What we do not know\nLong-term human outcomes when peptides are used with ongoing NSAID therapy are unknown. Dose-response relationships, optimal timing, and effects on different NSAID types lack clinical data. Whether any peptide meaningfully offsets NSAID-induced repair suppression in people remains untested.\n\n## Safety and limits\nNSAIDs carry established risks of gastrointestinal, renal, and cardiovascular effects. Peptides discussed in this context, such as BPC-157, have no approved human indications and limited published safety profiles. Animal studies report low toxicity for BPC-157, but human equivalence is unproven. Any approach combining compounds requires individualized medical oversight.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/what-are-peptides-nsaids/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"NSAIDs suppress inflammation signals and may slow structural repair cascades.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the core trade-off of symptom suppression versus repair for readers using NSAIDs.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat studies, BPC-157 reduced diclofenac-induced lesions in stomach, intestine, liver, and brain.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1","s3"],"source_status":"sourced","why_material":"Provides the primary animal evidence base for peptides counteracting NSAID toxicity.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 counteracted NSAID-induced drops in sphincter pressure and associated injuries in rats.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Shows broader organ protection in NSAID models beyond GI tract alone.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No published controlled human trials exist on peptides co-administered with NSAIDs.","section":"What the evidence actually shows","tier":"human","source_ids":["s3","s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for readers evaluating real-world applicability.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22950504/","title":"Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157","quote":"BPC 157 may be used as an antidote against NSAIDs... beneficial effects on stomach, duodenum, intestine, liver and brain injuries","summary":"Review summarizing rat studies where BPC-157 countered multiple NSAID toxicities.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T21:51:42.238Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"edac73dbb2404b952f6a5c3d6fd9ff041c3bc1ca98590e27aaafd983ea1ce853"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32445447/","title":"BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection","quote":"potential rescuing actions of BPC 157 against leaky gut syndrome after NSAIDs administration","summary":"Review on BPC-157 stabilizing gut barrier after NSAID exposure in preclinical models.","claim_ids":["c3","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T21:51:42.238Z","link_status":"ok","quote_status":"verified","prev":"edac73dbb2404b952f6a5c3d6fd9ff041c3bc1ca98590e27aaafd983ea1ce853","hash":"b3034b752d41a5174e6baf380099c7bed1e7f3b71ac188588706946df80d872f"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21781963/","title":"Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model","quote":"BPC 157 (10 μg/kg, 10 ng/kg) was strongly effective... counteraction of diclofenac-induced extensive toxicity","summary":"Rat study showing BPC-157 protection against diclofenac GI, liver, and encephalopathy lesions.","claim_ids":["c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T21:51:42.238Z","link_status":"ok","quote_status":"unverified","prev":"b3034b752d41a5174e6baf380099c7bed1e7f3b71ac188588706946df80d872f","hash":"21bd7b459145355bfe8ced0204ec7d7d19204efb841f3be3a065fef3373b22b2"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T21:51:43.826Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"What Are Peptides for NSAIDs","register":"source_ledger","body":"## What's breaking down\nNSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may damage the gut lining, liver, and other tissues. Repair pathways slow while new damage accumulates. The net result is ongoing structural stress even as symptoms feel quieter.\n\n## Why NSAIDs matters for you\n1. **Drug:** NSAIDs\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\n3. **Therefore for you:** NSAIDs primarily suppress a signal rather than reduce mechanical load or support metabolism. This trade-off can ease short-term discomfort but may delay tissue remodeling and repair cascades that rely on those same inflammatory pathways.\n\n## How these fit together\nPeptides studied alongside NSAIDs target different layers of the same problem. One layer is the inflammation NSAID use creates or fails to resolve. Another is the direct tissue injury NSAIDs can cause. A third is the slowed repair that follows signal suppression. When combined in research models, the peptide actions address cytoprotection and healing steps that the drug alone does not restore.\n\n## What the evidence actually shows\nHuman data on peptides specifically paired with NSAIDs remains absent in published trials. Preclinical (animal) studies form the main body of work. One rat study found BPC-157 reduced diclofenac-induced gastric, intestinal, liver, and brain lesions when given alongside or after the NSAID (source s1). Another rat model showed BPC-157 counteracted NSAID effects on lower esophageal and pyloric sphincter pressure and reduced associated injuries (source s2). A 2020 review summarized BPC-157's potential to stabilize intestinal permeability after NSAID exposure (source s3). These are all rodent or in-vitro findings; no equivalent controlled human trials exist for NSAID co-administration.\n\n## What scientists say\nResearchers note BPC-157's consistent cytoprotective effects in NSAID toxicity models across multiple organs in rats. They describe it as a possible adjunct for NSAID gastroenteropathy, an area with unmet needs (source s3, source s4). Human safety data for this use is described as unavailable. No large-scale clinical trials confirm translation from animal results.\n\n## What people say on Reddit\nUsers on peptide forums report taking BPC-157 while using NSAIDs and suggest spacing doses by two hours. Anecdotal accounts describe reduced gut discomfort or faster recovery from injuries while on anti-inflammatories. These remain individual experiences without controlled verification.\n\n## What people say on X\nPosts mention BPC-157 and TB-500 in contexts of injury recovery that sometimes involve prior NSAID use. Comments highlight perceived benefits for tendons or joints alongside warnings about limited human evidence and regulatory status. No consistent pattern of NSAID-specific stacking appears in recent threads.\n\n## What we do not know\nLong-term human outcomes when peptides are used with ongoing NSAID therapy are unknown. Dose-response relationships, optimal timing, and effects on different NSAID types lack clinical data. Whether any peptide meaningfully offsets NSAID-induced repair suppression in people remains untested.\n\n## Safety and limits\nNSAIDs carry established risks of gastrointestinal, renal, and cardiovascular effects. Peptides discussed in this context, such as BPC-157, have no approved human indications and limited published safety profiles. Animal studies report low toxicity for BPC-157, but human equivalence is unproven. Any approach combining compounds requires individualized medical oversight.","claims":[{"id":"c1","text":"NSAIDs suppress inflammation signals and may slow structural repair cascades.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the core trade-off of symptom suppression versus repair for readers using NSAIDs.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat studies, BPC-157 reduced diclofenac-induced lesions in stomach, intestine, liver, and brain.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the primary animal evidence base for peptides counteracting NSAID toxicity.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 counteracted NSAID-induced drops in sphincter pressure and associated injuries in rats.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Shows broader organ protection in NSAID models beyond GI tract alone.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No published controlled human trials exist on peptides co-administered with NSAIDs.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies the evidence gap for readers evaluating real-world applicability.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22950504/","title":"Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157","quote":"BPC 157 may be used as an antidote against NSAIDs... beneficial effects on stomach, duodenum, intestine, liver and brain injuries","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32445447/","title":"BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection","quote":"potential rescuing actions of BPC 157 against leaky gut syndrome after NSAIDs administration","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21781963/","title":"Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model","quote":"BPC 157 (10 μg/kg, 10 ng/kg) was strongly effective... counteraction of diclofenac-induced extensive toxicity","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":14960,"tokens_out":2577,"cost":0.0251425,"prev_hash":"genesis","hash":"afd08c2d187c9ff2c6a3e0e17a952a428db9dc6723e408c0535c90c084576939"}],"provenance":[{"ts":"2026-06-29T21:51:43.826Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: What Are Peptides for Nsaids\nSlug: what-are-peptides-nsaids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[],\"drugs_in_scope\":[\"nsaids\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[],\"drug_chains\":[{\"drug\":\"nsaids\",\"name\":\"NSAIDs\",\"section_title\":\"Why NSAIDs matters for you\",\"steps\":[\"**Drug:** NSAIDs\",\"**What it does:** Suppress inflammation signal; may slow structural repair cascade.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"],\"prose\":\"1. **Drug:** NSAIDs\\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n3. **Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"}],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\",\"section_headings\":[\"What's breaking down\",\"Why NSAIDs matters for you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What pe","response":"{\n  \"slug\": \"what-are-peptides-nsaids\",\n  \"title\": \"What Are Peptides for NSAIDs\",\n  \"body\": \"## What's breaking down\\nNSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may damage the gut lining, liver, and other tissues. Repair pathways slow while new damage accumulates. The net result is ongoing structural stress even as symptoms feel quieter.\\n\\n## Why NSAIDs matters for you\\n1. **Drug:** NSAIDs\\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n3. **Therefore for you:** NSAIDs primarily suppress a signal rather than reduce mechanical load or support metabolism. This trade-off can ease short-term discomfort but may delay tissue remodeling and repair cascades that rely on those same inflammatory pathways.\\n\\n## How these fit together\\nPeptides studied alongside NSAIDs target different layers of the same problem. One layer is the inflammation NSAID use creates or fails to resolve. Another is the direct tissue injury NSAIDs can cause. A third is the slowed repair that follows signal suppression. When combined in research models, the peptide actions address cytoprotection and healing steps that the drug alone does not restore.\\n\\n## What the evidence actually shows\\nHuman data on peptides specifically paired with NSAIDs remains absent in published trials. Preclinical (animal) studies form the main body of work. One rat study found BPC-157 reduced diclofenac-induced gastric, intestinal, liver, and brain lesions when given alongside or after the NSAID (source s1). Another rat model showed BPC-157 counteracted NSAID effects on lower esophageal and pyloric sphincter pressure and reduced associated injuries (source s2). A 2020 review summarized BPC-157's potential to stabilize intestinal permeability after NSAID exposure (source s3). These are all rodent or in-vitro finding","tokens_in":14960,"tokens_out":2577,"cost":0,"prev":"genesis","hash":"843ddcf954d3339a1106681449817b18daf26b383e7222d2a82a77ff19b258a1"},{"ts":"2026-07-17T02:43:33.658Z","model":"owner","action":"voxel_divide","prompt":"","input":"what-are-peptides-nsaids","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"843ddcf954d3339a1106681449817b18daf26b383e7222d2a82a77ff19b258a1","hash":"22436a2ec39e092892db1c5274604a5b7c9273c0bc6e7fff0e4b89522adb9f82"}],"energy":{"passes":2,"tokens_in":14960,"tokens_out":2577,"tokens_total":17537,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"22436a2ec39e092892db1c5274604a5b7c9273c0bc6e7fff0e4b89522adb9f82"},"posted_at":"2026-06-29T21:33:58.476Z","created_at":"2026-06-29T21:33:58.476Z","updated_at":"2026-07-17T02:43:33.658Z","machine":{"shape":"article.machine/v1","slug":"what-are-peptides-nsaids","kind":"article","read":{"human":"https://miscsubjects.com/a/what-are-peptides-nsaids","json":"https://miscsubjects.com/api/articles/what-are-peptides-nsaids","bundle":"https://miscsubjects.com/api/articles/what-are-peptides-nsaids/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/what-are-peptides-nsaids/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=what-are-peptides-nsaids","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"what-are-peptides-nsaids\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"what-are-peptides-nsaids\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/what-are-peptides-nsaids/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"what-are-peptides-nsaids\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/what-are-peptides-nsaids | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/what-are-peptides-nsaids","json":"/api/articles/what-are-peptides-nsaids","markdown":"/api/articles/what-are-peptides-nsaids/bundle?format=markdown","skill":"/api/articles/what-are-peptides-nsaids/skill","topology":"/api/articles/what-are-peptides-nsaids/topology","versions":"/api/articles/what-are-peptides-nsaids/revisions","invocations":"/api/articles/what-are-peptides-nsaids/invocations"},"editorial_review":null,"editorial_audit":{"slug":"what-are-peptides-nsaids","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"6ebf7259a35e46ac1f0565d09fadabc122ddde596bb206971071acc7b35fa33f","object":{"object_type":"article-object","identity":{"id":"article:what-are-peptides-nsaids","slug":"what-are-peptides-nsaids","title":"What Are Peptides for NSAIDs"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/what-are-peptides-nsaids","role":"explain","audience":"human"},"skill":{"route":"/api/articles/what-are-peptides-nsaids/skill","role":"direct behavior","audience":"model","content":"---\nname: what-are-peptides-nsaids\ndescription: Apply the What Are Peptides for NSAIDs article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# What Are Peptides for NSAIDs\n\nThis Skill is the behavioral expression of [the canonical article](/a/what-are-peptides-nsaids). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/what-are-peptides-nsaids.\n- Read claims and relationships at /api/articles/what-are-peptides-nsaids/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down NSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may d\n\n## Representations\n\n- Human: /a/what-are-peptides-nsaids\n- JSON: /api/articles/what-are-peptides-nsaids\n- Relationships: /api/articles/what-are-peptides-nsaids/topology\n- History: /api/articles/what-are-peptides-nsaids/revisions\n"},"json":{"route":"/api/articles/what-are-peptides-nsaids","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/what-are-peptides-nsaids/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","what","are","peptides","nsaids"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/what-are-peptides-nsaids/invocations?status=success","failure_events":"/api/articles/what-are-peptides-nsaids/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"what-are-peptides-nsaids","title":"What Are Peptides for NSAIDs","body":"## What's breaking down\nNSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may damage the gut lining, liver, and other tissues. Repair pathways slow while new damage accumulates. The net result is ongoing structural stress even as symptoms feel quieter.\n\n## Why NSAIDs matters for you\n1. **Drug:** NSAIDs\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\n3. **Therefore for you:** NSAIDs primarily suppress a signal rather than reduce mechanical load or support metabolism. This trade-off can ease short-term discomfort but may delay tissue remodeling and repair cascades that rely on those same inflammatory pathways.\n\n## How these fit together\nPeptides studied alongside NSAIDs target different layers of the same problem. One layer is the inflammation NSAID use creates or fails to resolve. Another is the direct tissue injury NSAIDs can cause. A third is the slowed repair that follows signal suppression. When combined in research models, the peptide actions address cytoprotection and healing steps that the drug alone does not restore.\n\n## What the evidence actually shows\nHuman data on peptides specifically paired with NSAIDs remains absent in published trials. Preclinical (animal) studies form the main body of work. One rat study found BPC-157 reduced diclofenac-induced gastric, intestinal, liver, and brain lesions when given alongside or after the NSAID (source s1). Another rat model showed BPC-157 counteracted NSAID effects on lower esophageal and pyloric sphincter pressure and reduced associated injuries (source s2). A 2020 review summarized BPC-157's potential to stabilize intestinal permeability after NSAID exposure (source s3). These are all rodent or in-vitro findings; no equivalent controlled human trials exist for NSAID co-administration.\n\n## What scientists say\nResearchers note BPC-157's consistent cytoprotective effects in NSAID toxicity models across multiple organs in rats. They describe it as a possible adjunct for NSAID gastroenteropathy, an area with unmet needs (source s3, source s4). Human safety data for this use is described as unavailable. No large-scale clinical trials confirm translation from animal results.\n\n## What people say on Reddit\nUsers on peptide forums report taking BPC-157 while using NSAIDs and suggest spacing doses by two hours. Anecdotal accounts describe reduced gut discomfort or faster recovery from injuries while on anti-inflammatories. These remain individual experiences without controlled verification.\n\n## What people say on X\nPosts mention BPC-157 and TB-500 in contexts of injury recovery that sometimes involve prior NSAID use. Comments highlight perceived benefits for tendons or joints alongside warnings about limited human evidence and regulatory status. No consistent pattern of NSAID-specific stacking appears in recent threads.\n\n## What we do not know\nLong-term human outcomes when peptides are used with ongoing NSAID therapy are unknown. Dose-response relationships, optimal timing, and effects on different NSAID types lack clinical data. Whether any peptide meaningfully offsets NSAID-induced repair suppression in people remains untested.\n\n## Safety and limits\nNSAIDs carry established risks of gastrointestinal, renal, and cardiovascular effects. Peptides discussed in this context, such as BPC-157, have no approved human indications and limited published safety profiles. Animal studies report low toxicity for BPC-157, but human equivalence is unproven. Any approach combining compounds requires individualized medical oversight.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/what-are-peptides-nsaids/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"NSAIDs suppress inflammation signals and may slow structural repair cascades.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the core trade-off of symptom suppression versus repair for readers using NSAIDs.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat studies, BPC-157 reduced diclofenac-induced lesions in stomach, intestine, liver, and brain.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1","s3"],"source_status":"sourced","why_material":"Provides the primary animal evidence base for peptides counteracting NSAID toxicity.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 counteracted NSAID-induced drops in sphincter pressure and associated injuries in rats.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Shows broader organ protection in NSAID models beyond GI tract alone.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No published controlled human trials exist on peptides co-administered with NSAIDs.","section":"What the evidence actually shows","tier":"human","source_ids":["s3","s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for readers evaluating real-world applicability.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22950504/","title":"Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157","quote":"BPC 157 may be used as an antidote against NSAIDs... beneficial effects on stomach, duodenum, intestine, liver and brain injuries","summary":"Review summarizing rat studies where BPC-157 countered multiple NSAID toxicities.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T21:51:42.238Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"edac73dbb2404b952f6a5c3d6fd9ff041c3bc1ca98590e27aaafd983ea1ce853"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32445447/","title":"BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection","quote":"potential rescuing actions of BPC 157 against leaky gut syndrome after NSAIDs administration","summary":"Review on BPC-157 stabilizing gut barrier after NSAID exposure in preclinical models.","claim_ids":["c3","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T21:51:42.238Z","link_status":"ok","quote_status":"verified","prev":"edac73dbb2404b952f6a5c3d6fd9ff041c3bc1ca98590e27aaafd983ea1ce853","hash":"b3034b752d41a5174e6baf380099c7bed1e7f3b71ac188588706946df80d872f"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21781963/","title":"Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model","quote":"BPC 157 (10 μg/kg, 10 ng/kg) was strongly effective... counteraction of diclofenac-induced extensive toxicity","summary":"Rat study showing BPC-157 protection against diclofenac GI, liver, and encephalopathy lesions.","claim_ids":["c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T21:51:42.238Z","link_status":"ok","quote_status":"unverified","prev":"b3034b752d41a5174e6baf380099c7bed1e7f3b71ac188588706946df80d872f","hash":"21bd7b459145355bfe8ced0204ec7d7d19204efb841f3be3a065fef3373b22b2"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T21:51:43.826Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"What Are Peptides for NSAIDs","register":"source_ledger","body":"## What's breaking down\nNSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may damage the gut lining, liver, and other tissues. Repair pathways slow while new damage accumulates. The net result is ongoing structural stress even as symptoms feel quieter.\n\n## Why NSAIDs matters for you\n1. **Drug:** NSAIDs\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\n3. **Therefore for you:** NSAIDs primarily suppress a signal rather than reduce mechanical load or support metabolism. This trade-off can ease short-term discomfort but may delay tissue remodeling and repair cascades that rely on those same inflammatory pathways.\n\n## How these fit together\nPeptides studied alongside NSAIDs target different layers of the same problem. One layer is the inflammation NSAID use creates or fails to resolve. Another is the direct tissue injury NSAIDs can cause. A third is the slowed repair that follows signal suppression. When combined in research models, the peptide actions address cytoprotection and healing steps that the drug alone does not restore.\n\n## What the evidence actually shows\nHuman data on peptides specifically paired with NSAIDs remains absent in published trials. Preclinical (animal) studies form the main body of work. One rat study found BPC-157 reduced diclofenac-induced gastric, intestinal, liver, and brain lesions when given alongside or after the NSAID (source s1). Another rat model showed BPC-157 counteracted NSAID effects on lower esophageal and pyloric sphincter pressure and reduced associated injuries (source s2). A 2020 review summarized BPC-157's potential to stabilize intestinal permeability after NSAID exposure (source s3). These are all rodent or in-vitro findings; no equivalent controlled human trials exist for NSAID co-administration.\n\n## What scientists say\nResearchers note BPC-157's consistent cytoprotective effects in NSAID toxicity models across multiple organs in rats. They describe it as a possible adjunct for NSAID gastroenteropathy, an area with unmet needs (source s3, source s4). Human safety data for this use is described as unavailable. No large-scale clinical trials confirm translation from animal results.\n\n## What people say on Reddit\nUsers on peptide forums report taking BPC-157 while using NSAIDs and suggest spacing doses by two hours. Anecdotal accounts describe reduced gut discomfort or faster recovery from injuries while on anti-inflammatories. These remain individual experiences without controlled verification.\n\n## What people say on X\nPosts mention BPC-157 and TB-500 in contexts of injury recovery that sometimes involve prior NSAID use. Comments highlight perceived benefits for tendons or joints alongside warnings about limited human evidence and regulatory status. No consistent pattern of NSAID-specific stacking appears in recent threads.\n\n## What we do not know\nLong-term human outcomes when peptides are used with ongoing NSAID therapy are unknown. Dose-response relationships, optimal timing, and effects on different NSAID types lack clinical data. Whether any peptide meaningfully offsets NSAID-induced repair suppression in people remains untested.\n\n## Safety and limits\nNSAIDs carry established risks of gastrointestinal, renal, and cardiovascular effects. Peptides discussed in this context, such as BPC-157, have no approved human indications and limited published safety profiles. Animal studies report low toxicity for BPC-157, but human equivalence is unproven. Any approach combining compounds requires individualized medical oversight.","claims":[{"id":"c1","text":"NSAIDs suppress inflammation signals and may slow structural repair cascades.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the core trade-off of symptom suppression versus repair for readers using NSAIDs.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat studies, BPC-157 reduced diclofenac-induced lesions in stomach, intestine, liver, and brain.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the primary animal evidence base for peptides counteracting NSAID toxicity.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 counteracted NSAID-induced drops in sphincter pressure and associated injuries in rats.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Shows broader organ protection in NSAID models beyond GI tract alone.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No published controlled human trials exist on peptides co-administered with NSAIDs.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies the evidence gap for readers evaluating real-world applicability.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T21:51:43.010Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22950504/","title":"Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157","quote":"BPC 157 may be used as an antidote against NSAIDs... beneficial effects on stomach, duodenum, intestine, liver and brain injuries","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32445447/","title":"BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection","quote":"potential rescuing actions of BPC 157 against leaky gut syndrome after NSAIDs administration","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21781963/","title":"Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model","quote":"BPC 157 (10 μg/kg, 10 ng/kg) was strongly effective... counteraction of diclofenac-induced extensive toxicity","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":14960,"tokens_out":2577,"cost":0.0251425,"prev_hash":"genesis","hash":"afd08c2d187c9ff2c6a3e0e17a952a428db9dc6723e408c0535c90c084576939"}],"provenance":[{"ts":"2026-06-29T21:51:43.826Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: What Are Peptides for Nsaids\nSlug: what-are-peptides-nsaids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[],\"drugs_in_scope\":[\"nsaids\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[],\"drug_chains\":[{\"drug\":\"nsaids\",\"name\":\"NSAIDs\",\"section_title\":\"Why NSAIDs matters for you\",\"steps\":[\"**Drug:** NSAIDs\",\"**What it does:** Suppress inflammation signal; may slow structural repair cascade.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"],\"prose\":\"1. **Drug:** NSAIDs\\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n3. **Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"}],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\",\"section_headings\":[\"What's breaking down\",\"Why NSAIDs matters for you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What pe","response":"{\n  \"slug\": \"what-are-peptides-nsaids\",\n  \"title\": \"What Are Peptides for NSAIDs\",\n  \"body\": \"## What's breaking down\\nNSAIDs reduce pain and swelling by blocking enzymes that produce inflammatory signals. This suppression can limit the body's natural repair signals that depend on controlled inflammation. Over time, the same drugs may damage the gut lining, liver, and other tissues. Repair pathways slow while new damage accumulates. The net result is ongoing structural stress even as symptoms feel quieter.\\n\\n## Why NSAIDs matters for you\\n1. **Drug:** NSAIDs\\n2. **What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n3. **Therefore for you:** NSAIDs primarily suppress a signal rather than reduce mechanical load or support metabolism. This trade-off can ease short-term discomfort but may delay tissue remodeling and repair cascades that rely on those same inflammatory pathways.\\n\\n## How these fit together\\nPeptides studied alongside NSAIDs target different layers of the same problem. One layer is the inflammation NSAID use creates or fails to resolve. Another is the direct tissue injury NSAIDs can cause. A third is the slowed repair that follows signal suppression. When combined in research models, the peptide actions address cytoprotection and healing steps that the drug alone does not restore.\\n\\n## What the evidence actually shows\\nHuman data on peptides specifically paired with NSAIDs remains absent in published trials. Preclinical (animal) studies form the main body of work. One rat study found BPC-157 reduced diclofenac-induced gastric, intestinal, liver, and brain lesions when given alongside or after the NSAID (source s1). Another rat model showed BPC-157 counteracted NSAID effects on lower esophageal and pyloric sphincter pressure and reduced associated injuries (source s2). A 2020 review summarized BPC-157's potential to stabilize intestinal permeability after NSAID exposure (source s3). These are all rodent or in-vitro finding","tokens_in":14960,"tokens_out":2577,"cost":0,"prev":"genesis","hash":"843ddcf954d3339a1106681449817b18daf26b383e7222d2a82a77ff19b258a1"},{"ts":"2026-07-17T02:43:33.658Z","model":"owner","action":"voxel_divide","prompt":"","input":"what-are-peptides-nsaids","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"843ddcf954d3339a1106681449817b18daf26b383e7222d2a82a77ff19b258a1","hash":"22436a2ec39e092892db1c5274604a5b7c9273c0bc6e7fff0e4b89522adb9f82"}],"energy":{"passes":2,"tokens_in":14960,"tokens_out":2577,"tokens_total":17537,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"22436a2ec39e092892db1c5274604a5b7c9273c0bc6e7fff0e4b89522adb9f82"},"posted_at":"2026-06-29T21:33:58.476Z","created_at":"2026-06-29T21:33:58.476Z","updated_at":"2026-07-17T02:43:33.658Z","machine":{"shape":"article.machine/v1","slug":"what-are-peptides-nsaids","kind":"article","read":{"human":"https://miscsubjects.com/a/what-are-peptides-nsaids","json":"https://miscsubjects.com/api/articles/what-are-peptides-nsaids","bundle":"https://miscsubjects.com/api/articles/what-are-peptides-nsaids/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/what-are-peptides-nsaids/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=what-are-peptides-nsaids","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"what-are-peptides-nsaids\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"what-are-peptides-nsaids\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/what-are-peptides-nsaids/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"what-are-peptides-nsaids\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/what-are-peptides-nsaids | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/what-are-peptides-nsaids","json":"/api/articles/what-are-peptides-nsaids","markdown":"/api/articles/what-are-peptides-nsaids/bundle?format=markdown","skill":"/api/articles/what-are-peptides-nsaids/skill","topology":"/api/articles/what-are-peptides-nsaids/topology","versions":"/api/articles/what-are-peptides-nsaids/revisions","invocations":"/api/articles/what-are-peptides-nsaids/invocations"},"editorial_review":null,"editorial_audit":{"slug":"what-are-peptides-nsaids","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"6ebf7259a35e46ac1f0565d09fadabc122ddde596bb206971071acc7b35fa33f"}}}